Intravitreal Bevacizumab for the Treatment of Chronic or Recurrent Central Serous Chorioretinopathy

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Open Journal of Ophthalmology

ISSN Print: 2165-7408
ISSN Online: 2165-7416
www.scirp.org/journal/ojoph
E-mail: ojoph@scirp.org

Citations h5-index & Ranking*

Journals Menu

"Intravitreal Bevacizumab for the Treatment of Chronic or Recurrent Central Serous Chorioretinopathy"
written by Mitzy E. Torres Soriano, Gerardo García Aguirre, Maximiliano Gordon Angelozzi, Veronica Kon Jara, Jans Fromow Guerra, Michael D. Ober, Hugo Quiroz Mercado,
published by Open Journal of Ophthalmology, Vol.4 No.3, 2014

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Evaluation of Visual Function Test of Central Serous Chorioretinopathy After Intravitreal Bevacizumab
	2019

[2]	Focal double‑frequency yttrium‑aluminum‑garnet laser in central serous chorioretinopathy resistant to intravitreal bevacizumab
	2015

[3]	INTRAVITREAL AVASTIN IN THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY
	Acta Ophthalmologica, 2015

[4]	Focal double-frequency yttrium-aluminum-garnet laser in central serous chorioretinopathy resistant to intravitreal bevacizumab
	2015

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Open Journal of Ophthalmology

Open Journal of Ophthalmology

Journals Menu

Home

About SCIRP

Service

Policies